Clinical Trials Directory

Trials / Completed

CompletedNCT03830567

Pharmacists Expand Access to Reproductive heaLthcare

Pharmacists Expand Access to Reproductive Healthcare: Reducing Unintended Pregnancy Through Pharmacist Prescription of Contraception

Status
Completed
Phase
Study type
Observational
Enrollment
471 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
Female
Age
18 Years – 51 Years
Healthy volunteers
Accepted

Summary

Prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates, as well as measures of safety and acceptability.

Detailed description

Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit or medical prescription, is a strategy to improve access to contraception and reduce unintended pregnancy. Oregon is the first state in the nation to implement legislation, as of January 1, 2016, expanding the scope of pharmacists to prescribe short-acting HCs. House Bill (HB) 2879 allows pharmacists to directly prescribe HC including the patch and pill, without a medical prescription. Women over 18 years of age can either initiate or continue HCs with a pharmacist, and women under 18 can continue a prescription. This prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist, aims to determine contraceptive continuation and incident pregnancy rates between women receiving hormonal contraception from a pharmacist versus other prescriber. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates.

Conditions

Interventions

TypeNameDescription
OTHERPharmacist prescriptionPharmacist prescribed hormonal contraception (initiation or continuation).
OTHERClinician prescriptionClinician prescribed hormonal contraception (initiation or continuation).

Timeline

Start date
2019-01-27
Primary completion
2021-02-02
Completion
2022-02-28
First posted
2019-02-05
Last updated
2024-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03830567. Inclusion in this directory is not an endorsement.